Kedudukan dalam Saham
#32150
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Harga Saham
$1.49
Disegerakkan terakhir: 2026-08-17
Perubahan (1 tahun)
-55.67%
Perdagangan Ainos, Inc. (AIMD)
Harga AIMD dengan permodalan pasaran b
Modal pasaran bagi Ainos, Inc.(AIMD)
Modal Pasaran: $10.94M
Sehingga August 2026, Ainos, Inc. mempunyai modal pasaran sebanyak $10.94M. Ini menjadikan Ainos, Inc. syarikat ke-32150th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Ainos, Inc. dari 2021 hingga 2026
AIMD berbanding dengan 5 teratas yang paling popular stocks
| Harga AIMD |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.460T
|
+49,926,451.49%
|
|
|
|
|
$4.489T
|
+41,050,947.33%
|
|
|
|
|
$4.141T
|
+37,863,476.22%
|
|
|
|
|
$3.569T
|
+32,629,940.70%
|
|
|
|
|
$2.798T
|
+25,584,584.04%
|
